Glucotrack (GCTK) Net Shares Issued and Repurchased (2012 - 2025)
Glucotrack's (GCTK) quarterly Net Shares Issued and Repurchased came in at $16220.0 in Q4 2025, up 14780.73% on a YoY basis from N/an in Q4 2024, and up 14780.73% quarter-over-quarter from $109.0 in Q4 2024.
Analysis
Glucotrack (GCTK) Net Shares Issued and Repurchased (2012 - 2025) Analysis & Trends
Glucotrack (GCTK) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $16220.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 14780.73% year-over-year to $16220.0; the trailing twelve-month figure through Dec 2025 stood at $16220.0 (up 14780.73% YoY), and the FY2025 full-year result was $16220.0, up 14780.73% from the prior year.
- Net Shares Issued and Repurchased climbed to $16220.0 in Q4 2025 per GCTK's latest filing, from $109.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $589.9 million in Q4 2021 and bottomed at $109.0 in Q4 2024.
- Historically, Net Shares Issued and Repurchased has averaged $185.6 million across 5 years, with a median of $115.9 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased tumbled 100.0% in 2024, then soared 14780.73% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $589.9 million in 2021, then tumbled by 80.36% to $115.9 million in 2022, then jumped by 91.63% to $222.0 million in 2023, then sank by 100.0% to $109.0 in 2024, then jumped by 14780.73% to $16220.0 in 2025.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $16220.0, $109.0, and $222.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.16 Bn | 175.56 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.68 Bn | 122.46 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.10 Bn | 108.28 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.81 Bn | 101.33 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.94 Bn | 45.69 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.07 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.42 Bn | 830.00 Mn | - |
| 9 | Steris | 20.77 Bn | 20.28 Bn | 684.20 Mn | - |
| 10 | Glucotrack | 1.06 Mn | -68,752.73 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16,220.00 |
| Dec 31, 2024 | 109.00 |
| Dec 31, 2023 | 222.02 Mn |
| Dec 31, 2022 | 115.86 Mn |
| Dec 31, 2021 | 589.93 Mn |
| Dec 31, 2020 | 25.77 Mn |
| Dec 31, 2019 | 2.04 Mn |
| Dec 31, 2018 | 2.04 Mn |
| Dec 31, 2017 | 4.74 Mn |
| Sep 30, 2017 | 292,924.00 |
| Mar 31, 2012 | 264,778.00 |